NM_004334.3:c.435A>G
Variant names:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_004334.3(BST1):c.435A>G(p.Arg145Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000501 in 1,614,056 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00029 ( 3 hom. )
Consequence
BST1
NM_004334.3 synonymous
NM_004334.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.288
Genes affected
BST1 (HGNC:1118): (bone marrow stromal cell antigen 1) Bone marrow stromal cell antigen-1 is a stromal cell line-derived glycosylphosphatidylinositol-anchored molecule that facilitates pre-B-cell growth. The deduced amino acid sequence exhibits 33% similarity with CD38. BST1 expression is enhanced in bone marrow stromal cell lines derived from patients with rheumatoid arthritis. The polyclonal B-cell abnormalities in rheumatoid arthritis may be, at least in part, attributed to BST1 overexpression in the stromal cell population. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 4-15707630-A-G is Benign according to our data. Variant chr4-15707630-A-G is described in ClinVar as [Benign]. Clinvar id is 717839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.288 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BST1 | ENST00000265016.9 | c.435A>G | p.Arg145Arg | synonymous_variant | Exon 3 of 9 | 1 | NM_004334.3 | ENSP00000265016.4 | ||
BST1 | ENST00000382346.7 | c.480A>G | p.Arg160Arg | synonymous_variant | Exon 4 of 10 | 5 | ENSP00000371783.3 | |||
BST1 | ENST00000505785.5 | c.120A>G | p.Arg40Arg | synonymous_variant | Exon 1 of 7 | 2 | ENSP00000423357.1 |
Frequencies
GnomAD3 genomes AF: 0.00251 AC: 382AN: 152100Hom.: 2 Cov.: 31
GnomAD3 genomes
AF:
AC:
382
AN:
152100
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000628 AC: 158AN: 251456Hom.: 1 AF XY: 0.000441 AC XY: 60AN XY: 135902
GnomAD3 exomes
AF:
AC:
158
AN:
251456
Hom.:
AF XY:
AC XY:
60
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000291 AC: 425AN: 1461838Hom.: 3 Cov.: 32 AF XY: 0.000252 AC XY: 183AN XY: 727228
GnomAD4 exome
AF:
AC:
425
AN:
1461838
Hom.:
Cov.:
32
AF XY:
AC XY:
183
AN XY:
727228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00252 AC: 383AN: 152218Hom.: 2 Cov.: 31 AF XY: 0.00226 AC XY: 168AN XY: 74434
GnomAD4 genome
AF:
AC:
383
AN:
152218
Hom.:
Cov.:
31
AF XY:
AC XY:
168
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 20, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at